Cargando…
Combination of lymphocyte count and not the serological response with high-sensitivity cardiac troponin for risk stratification in patients with possible COVID-19
Autores principales: | Kittanakom, Saranya, Kavsak, Peter A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8139183/ https://www.ncbi.nlm.nih.gov/pubmed/34023285 http://dx.doi.org/10.1016/j.cca.2021.05.018 |
Ejemplares similares
-
Important Differences Between Manufacturers When Transitioning From a Contemporary Cardiac Troponin Assay to a High-Sensitivity Cardiac Troponin Assay
por: Kavsak, Peter A., et al.
Publicado: (2021) -
Incidence and Etiology of Poor Duplicate Ortho High-Sensitivity Cardiac Troponin I Results in a Community Hospital Emergency Department
por: Kavsak, Peter A., et al.
Publicado: (2022) -
Admission High-Sensitivity Cardiac Troponin vs a Biochemical Score for Predicting Mortality in Patients With COVID-19
por: Kavsak, Peter A., et al.
Publicado: (2020) -
High-Sensitivity Cardiac Troponin Publications during the COVID-19 Pandemic (2020–2022)
por: Kavsak, Peter A.
Publicado: (2022) -
High-Sensitivity Cardiac Troponin I and T for Cardiovascular Risk Stratification in Adults With Diabetes
por: Tang, Olive, et al.
Publicado: (2020)